about
Engineering of a broad specificity antibody for simultaneous detection of 13 sulfonamides at the maximum residue level.Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells.Cerebrospinal fluid findings in multiple sclerosis patients before, during and after pregnancy.Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.Postpartum activation of multiple sclerosis: MRI imaging and immunological characterization of a case.Humoral response to John Cunningham virus during pregnancy in multiple sclerosis.Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cellsClinical and immunologic evaluation of women with multiple sclerosis during and after pregnancyExpansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
P50
Q33196543-46448577-89B1-45F5-8CAD-DBB201E89B41Q37365081-A724AAD0-C7C6-4C5C-9987-17CB95D97C91Q42718471-6599D522-8E82-4652-8E9F-1D4093DD9B05Q46683361-545A4D62-446E-43FE-8289-F5106A53EDA8Q46899421-DCA2C44E-E392-4D72-B4D5-3D53CBE27A5BQ49903222-2AF13A11-8742-42C9-AFB1-F16F62A54133Q80154712-B55A4C06-695E-4304-8679-62C4F9CA4B00Q80512221-9443587C-775E-4083-9CA4-C4A87757048FQ80551920-2E6565AC-A718-48F8-81E0-FA5234EC33DA
P50
description
researcher
@en
wetenschapper
@nl
name
Maija Saraste
@en
Maija Saraste
@nl
type
label
Maija Saraste
@en
Maija Saraste
@nl
prefLabel
Maija Saraste
@en
Maija Saraste
@nl
P106
P31
P496
0000-0002-3424-5976